Found: 21
Select item for more details and to access through your institution.
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1086, doi. 10.1634/theoncologist.2017-0095
- By:
- Publication type:
- Article
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1028, doi. 10.1634/theoncologist.2017-0072
- By:
- Publication type:
- Article
A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1024, doi. 10.1634/theoncologist.2017-0175
- By:
- Publication type:
- Article
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1039, doi. 10.1634/theoncologist.2017-0142
- By:
- Publication type:
- Article
Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1125, doi. 10.1634/theoncologist.2017-0009
- By:
- Publication type:
- Article
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1075, doi. 10.1634/theoncologist.2016-0331
- By:
- Publication type:
- Article
The Patients We Have to See.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1020, doi. 10.1634/theoncologist.2017-0172
- By:
- Publication type:
- Article
On the Receiving End of Autonomy and Law.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1143, doi. 10.1634/theoncologist.2016-0404
- By:
- Publication type:
- Article
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1056, doi. 10.1634/theoncologist.2017-0015
- By:
- Publication type:
- Article
Perceptions of Cancer Care and Clinical Trials in the Black Community: Implications for Care Coordination Between Oncology and Primary Care Teams.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1094, doi. 10.1634/theoncologist.2017-0122
- By:
- Publication type:
- Article
Transitions in Prognostic Awareness Among Terminally Ill Cancer Patients in Their Last 6 Months of Life Examined by Multi-State Markov Modeling.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1135, doi. 10.1634/theoncologist.2017-0068
- By:
- Publication type:
- Article
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1049, doi. 10.1634/theoncologist.2016-0178
- By:
- Publication type:
- Article
Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Appendiceal Mucinous Neoplasms: Diagnosis and Management.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1107, doi. 10.1634/theoncologist.2017-0081
- By:
- Publication type:
- Article
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer--The GCIG Symptom Benefit Study.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1117, doi. 10.1634/theoncologist.2017-0047
- By:
- Publication type:
- Article
Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma--A New Look at an Old Drug.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1102, doi. 10.1634/theoncologist.2016-0459
- By:
- Publication type:
- Article
The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
The Impact of a Hepatobiliary Multidisciplinary Team Assessment in Patients with Colorectal Cancer Liver Metastases: A Population-Based Study.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1067, doi. 10.1634/theoncologist.2017-0028
- By:
- Publication type:
- Article
Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1026, doi. 10.1634/theoncologist.2017-0060
- By:
- Publication type:
- Article
Chemo Heart.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1146, doi. 10.1634/theoncologist.2017-0110
- By:
- Publication type:
- Article
Commentary on "Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data".
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1022, doi. 10.1634/theoncologist.2017-0232
- By:
- Publication type:
- Article